1
TITLE: Safety and Tolerability of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM-HNSCC)
AUTHORS: Colevas, A. D.; Kerrigan, K.; Chin, V.; Rainey, N.; Park, J. J.; Fang, B.; Alpuim Costa, D.; Dinis, J.; Phan, M.; Lin, L.; Zhang, Y.; Sun, S. C. C.; Howland, M.; Curtis, K.; Adkins, D.;
PUBLISHED: 2024, SOURCE: Multidisciplinary Head and Neck Cancers Symposium in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, VOLUME: 118, ISSUE: 5
INDEXED IN: WOS
2
TITLE: A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC
AUTHORS: Colevas, A. Dimitrios Dimitrios; Dinis, Jose Prime; Chin, Venessa T.; Costa, Diogo Alpuim; Park, John J.; Fang, Bruno; Phan, Minh Duc; Zhang, Yiran; U'Ren, Lance; Odegard, Jared; Curtis, Kelly Kevelin; Pirtle, Erika; Adkins, Douglas;
PUBLISHED: 2023, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41, ISSUE: 16
INDEXED IN: WOS